---
filename: endocrine-crises.md
id: endocrine-crises
title: Endocrine Crises
slug: endocrine-crises
tags: [endocrinology, inpatient, night-float]
level: resident
estimated_time_min: 25
version: 2026-02-21
source: IM_NightFloat_Engine
---

# Endocrine Crises

## Panic Card
- ABCs, monitor, large-bore IVs, bedside glucose; treat shock with balanced crystalloids and target **MAP ≥65 mmHg** while sending core labs (BMP, VBG/ABG, serum ketones/β‑hydroxybutyrate, osmolality, TSH/FT4/FT3 if thyrotoxic, cortisol if feasible) and infection workup. citeturn2search1turn2search13
- Suspected adrenal crisis: give **hydrocortisone 100 mg IV now**, then **200 mg/24 h** (continuous or 50 mg IV q6h); do not delay for labs. citeturn2search41turn2search42
- DKA/HHS: start fluids first; begin insulin only when **K⁺ ≥3.3 mmol/L** and continue close K⁺ repletion; add dextrose when glucose approaches **~11.1–13.9 mmol/L (200–250 mg/dL)**. citeturn2search13
- Thyroid storm: **β‑blocker (esmolol or propranolol)**, give **thionamide (PTU or methimazole)**, then **iodine ≥1 h later**, plus **glucocorticoid**; avoid aspirin. citeturn2search53turn2search31
- Myxedema coma: passive rewarming, ventilatory support, **IV levothyroxine 200–400 mcg** (with or without low‑dose liothyronine) and empiric stress‑dose steroids. citeturn2search11
- Severe hypercalcemia (≥**3.5 mmol/L** [**14 mg/dL**]): aggressive isotonic fluids, **calcitonin**, and **denosumab or IV bisphosphonate**; limit calcitonin to 48–72 h. citeturn2search47turn2search50

## Brief Overview
- Endocrine emergencies on call commonly include **DKA/HHS**, **adrenal crisis**, **thyroid storm**, **myxedema coma**, and **hypercalcemic crisis**; prioritize hemodynamics, oxygenation, fluids, and rapid, guideline‑based disease‑specific therapy. citeturn2search1turn2search13
- **Guideline Must‑Know:** For DKA/HHS, 2024 ADA/EASD consensus emphasizes three treatment pillars—**fluids, insulin, potassium**—with quantitative **β‑hydroxybutyrate** preferred for diagnosis and resolution criteria. citeturn2search13
- **Guideline Must‑Know:** Start insulin only after **K⁺ ≥3.3 mmol/L**; replete K⁺ if 3.3–5.2 mmol/L and hold insulin if <3.3 mmol/L; monitor K⁺ and glucose hourly in early therapy. citeturn2search13
- **Guideline Must‑Know:** ADA “Diabetes Care in the Hospital—2025” recommends inpatient glycemic targets **7.8–10.0 mmol/L (140–180 mg/dL)** for most adults and structured order sets for dysglycemia. citeturn2search20
- **Guideline Must‑Know:** Thyroid storm requires **β‑blocker → thionamide → iodine (≥1 h later) + glucocorticoid**; use **PTU** if severe and early due to T4→T3 inhibition; choose **esmolol** if decompensated HF. citeturn2search53
- **Guideline Must‑Know:** Japan Thyroid Association/JES 2016 supports multimodal therapy and ICU admission criteria for storm (organ failure, severe CHF, shock); Burch‑Wartofsky is supportive but **diagnosis is clinical**. citeturn2search31turn2search30
- **Guideline Must‑Know:** Myxedema coma management centers on airway/ventilation, cautious fluids, **IV levothyroxine 200–400 mcg** (± liothyronine), and empiric hydrocortisone until AI is excluded. citeturn2search11
- **Guideline Must‑Know:** Adrenal crisis: **hydrocortisone 100 mg IV bolus → 200 mg/24 h infusion or 50 mg IV q6h** plus isotonic fluids; draw cortisol/ACTH if feasible but **do not delay treatment**. citeturn2search41turn2search42
- **Guideline Must‑Know:** Hypercalcemia of malignancy: give isotonic fluids, **calcitonin** for rapid effect (tachyphylaxis ≤72 h), and **denosumab preferred** over IV bisphosphonate when feasible; treat tumor to prevent recurrence. citeturn2search50turn2search48
- In suspected sepsis overlap (DKA/HHS with infection), apply sepsis bundles and pressor targets (**MAP ≥65 mmHg**) while avoiding rapid sodium correction beyond **8–10 mmol/L/24 h**. citeturn2search1
- Distinguish **DKA** (acidosis/ketosis) from **HHS** (hyperosmolality, minimal ketosis); some patients have overlap; the 2024 consensus adds explicit **HHS resolution criteria**. citeturn2search13
- SGLT2 inhibitor‑associated **euglycemic DKA** presents with normal or mildly elevated glucose; still requires insulin, dextrose‑containing fluids, and stopping the SGLT2. citeturn2search13
- For storm with AF and decompensated HF, use **short‑acting β‑blocker (esmolol)** under monitoring; avoid high‑dose propranolol in shock; consider early ICU and cooling. citeturn2search53
- Myxedema coma pitfalls: avoid active external rewarming (risk of vasodilation collapse), check for precipitating infection, **correct hyponatremia slowly**; ventilatory support often required. citeturn2search11
- Hypercalcemic crisis pearls: correct volume deficit first; avoid loop diuretics until euvolemia; consider **zoledronic acid 4 mg IV** or **denosumab 120 mg SC**; expect effect in 24–72 h (use calcitonin for bridging). citeturn2search50
- What must happen now: stabilize ABCs, fluids, focused labs, start disease‑specific therapy (hydrocortisone for suspected AI; insulin for DKA/HHS when K⁺ safe; β‑blocker/thionamide/iodine/steroid for storm; IV LT4 for coma; fluids+calcitonin+antiresorptive for hypercalcemia). citeturn2search13turn2search41turn2search53turn2search11turn2search50
- What can wait (after stabilization): identify triggers (infection, drugs, nonadherence), transition to subcutaneous insulin, endocrine testing refinement, and oncologic therapy planning. citeturn2search20

## Top ICU/Consult Triggers
- Shock or pressor need, **pH <7.0**, **K⁺ <2.5 or >6.0 mmol/L**, **effective osmolality ≥320 mOsm/kg** with altered mental status, or refractory hypoventilation/hypercapnia. citeturn2search13
- Thyroid storm with heart failure, arrhythmia refractory to β‑blockade, or multiorgan failure; myxedema coma with hypothermia and CO₂ retention requiring ventilatory support. citeturn2search53turn2search31turn2search11
- Severe hypercalcemia **(≥3.5 mmol/L [14 mg/dL])** with neurologic changes or renal failure despite initial therapy. citeturn2search50

## Orders to Place Now
- Order: Balanced crystalloid bolus/infusion — {rate mL/h, reassess MAP ≥65 mmHg, urine output, lactate} citeturn2search1
- Order: Insulin infusion (DKA/HHS) — {start when K⁺ ≥3.3 mmol/L; initial 0.1 U/kg/h; add D10/½NS when glucose ≤11.1–13.9 mmol/L (200–250 mg/dL)} citeturn2search13
- Order: Potassium chloride replacement — {hold insulin if K⁺ <3.3; replace to 4.0–5.0 mmol/L; telemetry} citeturn2search13
- Order: Hydrocortisone stress dosing — {100 mg IV now, then 50 mg IV q6h or 200 mg/24 h infusion} citeturn2search41
- Order: Thyroid storm bundle — {esmolol infusion titration; methimazole {dose} or PTU {dose}; iodine {start ≥1 h after thionamide}; dexamethasone {dose}} citeturn2search53turn2search31
- Order: Hypercalcemia therapy — {calcitonin 4 IU/kg SC/IM q12h × 48–72 h max; denosumab 120 mg SC now or zoledronic acid 4 mg IV once; aggressive isotonic fluids} citeturn2search50

## ABIM‑Style Question 1

### Stem
A 45‑year‑old with type 1 diabetes presents with abdominal pain, Kussmaul respirations, and dehydration. Labs: glucose 28 mmol/L (504 mg/dL), β‑hydroxybutyrate 5.0 mmol/L, pH 7.23, HCO₃⁻ 14 mmol/L, anion gap 22, **K⁺ 2.9 mmol/L**. Vitals: HR 118, BP 104/62.

### Options
A. Start IV regular insulin at 0.1 U/kg/h immediately  
B. Give 1 ampule IV sodium bicarbonate and start insulin  
C. Begin isotonic fluids and **replete potassium first**, then start insulin when K⁺ ≥3.3 mmol/L  
D. Start dextrose 10% infusion now to prevent hypoglycemia  
E. Administer subcutaneous rapid‑acting insulin 0.2 U/kg every 2 hours

### Correct answer
C

### Rationale
Insulin therapy is **contraindicated until K⁺ ≥3.3 mmol/L** due to arrhythmia risk; initiate fluids and aggressive potassium replacement first, then insulin infusion with hourly monitoring. Bicarbonate is not indicated at pH 7.23. Subcutaneous insulin may be used for mild‑moderate DKA in selected settings, but the immediate priority here is potassium correction before any insulin. citeturn2search13

## Second ABIM‑Style Case (Pitfall Variant)

### Stem
A 62‑year‑old woman on empagliflozin presents with malaise and nausea. Vitals: HR 110, BP 112/68, RR 22. Labs: glucose 10.7 mmol/L (193 mg/dL), β‑hydroxybutyrate 3.8 mmol/L, pH 7.28, HCO₃⁻ 16 mmol/L, anion gap 18, K⁺ 4.2 mmol/L. UA: ketonuria. She is euvolemic.

### Options
A. Reassure; normal glucose excludes DKA  
B. Start insulin infusion with dextrose‑containing fluids; stop SGLT2 inhibitor  
C. Give bicarbonate infusion until pH >7.35  
D. Start basal insulin only and observe  
E. Treat as HHS with aggressive fluids only

### Correct answer
B

### Rationale
This is **euglycemic DKA** associated with SGLT2 inhibitors; treatment mirrors DKA with **insulin plus dextrose‑containing fluids** to suppress ketogenesis while avoiding hypoglycemia; discontinue the SGLT2 agent. The pitfall is dismissing DKA because glucose is not markedly elevated. citeturn2search13

What changed the decision here?

## Check‑Yourself Micro‑Questions
- Q: Minimum K⁺ level before starting IV insulin in DKA/HHS?  
  A: **≥3.3 mmol/L**; correct K⁺ below this threshold before insulin due to arrhythmia risk. citeturn2search13
- Q: Initial steroid and dose for suspected adrenal crisis?  
  A: **Hydrocortisone 100 mg IV**, then **200 mg over 24 h** (continuous or 50 mg IV q6h). citeturn2search41
- Q: Sequence for thyroid storm antithyroid therapy?  
  A: **β‑blocker → thionamide → iodine (≥1 h later) + glucocorticoid**. citeturn2search53
- Q: Severe hypercalcemia threshold and first‑line antiresorptives?  
  A: **≥3.5 mmol/L (14 mg/dL)**; use **denosumab** or **IV bisphosphonate**, with **calcitonin** as bridge. citeturn2search50

## Guidelines & Key References
- ADA/EASD/AACE/JBDS/DTS. **Hyperglycemic Crises in Adults With Diabetes—Consensus Report (2024)**. Diabetes Care. https://diabetesjournals.org/care/article/47/8/1257/156808/ citeturn2search13
- ADA. **Standards of Care in Diabetes—2025: Diabetes Care in the Hospital**. Diabetes Care (Suppl 1). https://diabetesjournals.org/care/article/48/Supplement_1/S321/157551/ citeturn2search20
- American Thyroid Association. **2016 Hyperthyroidism/Thyrotoxicosis Guideline** (storm management). https://www.liebertpub.com/doi/pdf/10.1089/thy.2016.0229 citeturn2search53
- Japan Thyroid Association/JES. **2016 Thyroid Storm Management Guideline**. https://www.eurothyroid.com/files/download/japan-guidelines-thyroid-storm-2016.pdf citeturn2search31
- Endocrine Society. **Primary Adrenal Insufficiency Guideline (2016)**. https://www.endocrine.org/clinical-practice-guidelines/primary-adrenal-insufficiency citeturn2search41
- Endocrine Society. **Treatment of Hypercalcemia of Malignancy in Adults (2022)**. https://academic.oup.com/jcem/article/108/3/507/6916871 citeturn2search50

## CDI: What to Document Clearly Tonight
- Diabetic ketoacidosis or hyperosmolar hyperglycemic state: acuity, severity (pH/HCO₃⁻/β‑hydroxybutyrate/osmolality), precipitant (infection, nonadherence, SGLT2 inhibitor), objective values, and insulin/fluids/electrolyte therapy.
- Adrenal crisis due to primary/secondary adrenal insufficiency: trigger, hypotension/shock, electrolyte abnormalities (hyponatremia/hyperkalemia), cortisol/ACTH if obtained, and hydrocortisone dosing/response.
- Thyroid storm: etiology (Graves’, toxic nodular), organ dysfunction (fever, CNS, CHF, arrhythmia), specific sequence of β‑blocker → thionamide → iodine → steroid, and ICU need.
- Myxedema coma: precipitant, hypothermia, ventilatory failure, hyponatremia, IV levothyroxine dose (± liothyronine), empiric steroids, and ventilatory support.
- Hypercalcemia of malignancy: severity (peak corrected/ionized Ca²⁺), etiology (PTHrP/osteolytic/calcitriol), renal/neurologic impact, fluids + calcitonin and **denosumab/IV bisphosphonate**, and oncology plan. citeturn2search50
